Details

NameSymbolSector
WINDLAS BIOTECH LIMITEDWINDLASPharmaceuticals
Open
950.15
High
955.05
Low
925.65
Close
940.15
Volume
28163
Exchange
nse
Time
03-Oct-2025

Outlook

Score:  

2.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Windlas Biotech is  
None
Estimated Stoploss of Windlas Biotech is ₹  
955.05
Windlas Biotech has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Windlas Biotech is  
Unpredictableℹ
. 

Trend

Windlas Biotech is in  
Sideways trendℹ
. 
Price of Windlas Biotech is  
Downℹ
 by  

3.18

%. 
Target
Buy @ 

883.81

Sell @ 

1051.15

Current @ 

940.15

Volume

The trade volumes of Windlas Biotech have become  
Deficientℹ
The volume trend for Windlas Biotech is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Windlas Biotech is  

Down

 by  

57.34

% 

Valuation

The current market price of Windlas Biotech is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 760cr and total assets worth ₹ 760cr, the balance sheet of Windlas Biotech is:  
Balancedℹ
. 
Cashflow
Windlas Biotech has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 4cr

. It is  
Downℹ
 by  

500

%. 

(*Mar 2025)

47.55% i.e. ₹ 68cr earned in operatingℹ
51.75% i.e. ₹ 74cr spent in investingℹ
0.7% i.e. ₹ 1cr earned in financingℹ
0% in otherℹ
Windlas Biotech has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 1cr

. It is  
Downℹ
 by  

66.67

%. 

(*Mar 2024)

50.23% i.e. ₹ 108cr earned in operatingℹ
42.79% i.e. ₹ 92cr spent in investingℹ
6.98% i.e. ₹ 15cr spent in financingℹ
0% in otherℹ
Income
The income of Windlas Biotech is  

₹ 215cr

 and  

Profit

 is :  

₹ 17cr

(*Jun 2025)

Windlas Biotech Profit is up by:  

6.25

% and Income is Up by:  

3.86

% 

(*Jun 2025)

The income of Windlas Biotech is  

₹ 207cr

 and  

Profit

 is :  

₹ 16cr

(*Mar 2025)

Windlas Biotech Profit is up by:  

6.67

% and Income is Up by:  

4.02

% 

(*Mar 2025)

The income of Windlas Biotech is  

₹ 199cr

 and  

Profit

 is :  

₹ 15cr

(*Dec 2024)

Windlas Biotech Profit is up by:  

0

% and Income is Up by:  

4.19

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.